Cytoblastin (Vinblastine Sulphate) Intravenous Injection Is Indicated in the Treatment of Several Different Forms of Cancer Including Hodgkin's Disease, Lymphocytic Lymphoma, Histiocytic Lymphoma, Mycosis Fungoides, and Carcinoma of the Testes, Kaposi's Sarcoma and Letterer-siwe Disease (Histiocytosis X). Vinblastine Sulphate Is What Is Know as a Vinca Alkaloid. Its Mechanism of Action Is the Inhibition of Microtubule Formation in the Mitotic Spindle Within Cancer Cells. This Results in the Slowing of Their Replication and the Spread of the Cancer.
Cytoblastin Can Only Be Administered by Intravenous Injection. If Vinblastine Is Administered via Any Other Route It Can Become Fatal.
Your Individualized Dosage Will Be Prescribed by Your Doctor and Is Dependent on the Type of Cancer Being Treated and a Variety of Personal Factors. A Starting Dosage 3.7mg/m2 of Body Surface Area Is Often Prescribed for Adults, but This Is a Guideline Only. Follow the Exact Instructions Provided by Your Doctor. Do Not Exceed a Maximum Dose of 18.5 Mg/m2 Body Surface Area.
Cytoblastin (Vinblastine) Can Result in Some Unwanted Side Effects Including:
Tell Your Doctor if You Experience Any of the Above While Taking Cytoblastin (Vinblastine Sulphate).